Related Articles
SPECIFIC RECOGNITION OF A TRANSCRIPTIONAL ELEMENT WITHIN THE HUMAN H-RAS PROTOONCOGENE BY THE P53 TUMOR-SUPPRESSOR
BINDING OF THE GLUCOCORTICOID AND ESTROGEN-RECEPTORS TO THE HUMAN H-RAS ONCOGENE SEQUENCES
BINDING OF WILD-TYPE AND MUTANT FORMS OF P53 PROTEIN FROM HUMAN TUMORS TO A SPECIFIC DNA-SEQUENCE OF THE FIRST INTRON OF THE H-RAS ONCOGENE
Disruption of functions of wild-type p53 by hetero-oligomerization.
Farnesyl transferase inhibitor FTI-277 inhibits breast cell invasion and migration by blocking H-Ras activation